Published in Proc Natl Acad Sci U S A on September 29, 1998
AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature (2001) 5.47
From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer (2009) 4.15
AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell (2008) 4.13
The connection between transcription and genomic instability. EMBO J (2002) 3.44
Origin of chromosomal translocations in lymphoid cancer. Cell (2010) 2.94
Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell (2010) 2.92
Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol (2010) 2.80
AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell (2009) 2.75
Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A (2004) 2.30
Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood (2012) 2.30
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity (2001) 1.98
A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J Exp Med (2011) 1.97
Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc Natl Acad Sci U S A (2006) 1.95
Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med (2008) 1.80
Regulation of class switch recombination and somatic mutation by AID phosphorylation. J Exp Med (2008) 1.78
Somatic hypermutation of the AID transgene in B and non-B cells. Proc Natl Acad Sci U S A (2002) 1.71
Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol (2009) 1.64
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood (2009) 1.64
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.62
Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med (2009) 1.61
B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell (2014) 1.58
Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci U S A (2003) 1.55
RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle. Cell Rep (2013) 1.53
Detection of chromatin-associated single-stranded DNA in regions targeted for somatic hypermutation. J Exp Med (2007) 1.46
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. J Exp Med (2002) 1.45
Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med (2000) 1.40
Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med (2012) 1.40
Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med (2000) 1.40
BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J Exp Med (2003) 1.36
Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol (2011) 1.36
Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci U S A (2002) 1.30
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol (2003) 1.27
Error-prone candidates vie for somatic mutation. J Exp Med (2000) 1.27
Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A (2002) 1.26
A role for AID in chromosome translocations between c-myc and the IgH variable region. J Exp Med (2007) 1.22
Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol (1999) 1.20
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res (2009) 1.19
The genetic basis of diffuse large B-cell lymphoma. Curr Opin Hematol (2013) 1.12
Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair. Adv Immunol (2014) 1.11
Recurrent targets of aberrant somatic hypermutation in lymphoma. Oncotarget (2012) 1.11
Molecular pathogenesis of diffuse large B-cell lymphoma. Semin Diagn Pathol (2011) 1.11
Germinal centers in human lymph nodes contain reactivated memory B cells. J Exp Med (2007) 1.09
The very 5' end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J Exp Med (2005) 1.06
Differential regulation of histone acetylation and generation of mutations in switch regions is associated with Ig class switching. Proc Natl Acad Sci U S A (2004) 1.03
Attracting AID to targets of somatic hypermutation. J Exp Med (2010) 1.03
A comprehensive analysis of the effects of the deaminase AID on the transcriptome and methylome of activated B cells. Nat Immunol (2013) 0.97
Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol (2004) 0.96
Somatic hypermutation of immunoglobulin and non-immunoglobulin genes. Philos Trans R Soc Lond B Biol Sci (2001) 0.96
Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci U S A (2009) 0.96
Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences. PLoS Biol (2014) 0.95
BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements. Blood (2013) 0.95
Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog (2012) 0.95
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer (2004) 0.94
AID and Apobec3G haphazard deamination and mutational diversity. Cell Mol Life Sci (2012) 0.93
Activation-induced cytidine deaminase in antibody diversification and chromosome translocation. Adv Cancer Res (2012) 0.92
Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation. Mol Cell Biol (2010) 0.92
Related Mechanisms of Antibody Somatic Hypermutation and Class Switch Recombination. Microbiol Spectr (2015) 0.90
Separation of mutational and transcriptional enhancers in Ig genes. J Immunol (2011) 0.90
AID/APOBEC deaminases and cancer. Oncoscience (2015) 0.89
AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells. PLoS One (2012) 0.89
The genetic landscape of diffuse large B-cell lymphoma. Semin Hematol (2015) 0.88
Peripheral T-cell lymphoma with involvement of the expanded mantle zone. Virchows Arch (2006) 0.87
The majority of human memory B cells recognizing RhD and tetanus resides in IgM+ B cells. J Immunol (2014) 0.87
A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. PLoS Pathog (2013) 0.87
AID-mediated diversification within the IgL locus of chicken DT40 cells is restricted to the transcribed IgL gene. Mol Immunol (2007) 0.86
The BRCT domain of PARP-1 is required for immunoglobulin gene conversion. PLoS Biol (2010) 0.86
Life and death within germinal centres: a double-edged sword. Immunology (2002) 0.86
Molecular pathology of lymphoma. Eye (Lond) (2012) 0.86
AID targeting: old mysteries and new challenges. Trends Immunol (2015) 0.84
A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas. Am J Pathol (2002) 0.84
Targeting of AID-mediated sequence diversification to immunoglobulin genes. Curr Opin Immunol (2011) 0.83
In vivo and in vitro studies of immunoglobulin gene somatic hypermutation. Philos Trans R Soc Lond B Biol Sci (2001) 0.83
Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. Nat Commun (2013) 0.83
Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat Rev Immunol (2016) 0.82
Generation and repair of AID-initiated DNA lesions in B lymphocytes. Front Med (2014) 0.81
Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome. Transl Oncol (2009) 0.80
Follicular lymphomas: a tapestry of common and contrasting threads. Haematologica (2013) 0.80
A critical context-dependent role for E boxes in the targeting of somatic hypermutation. J Immunol (2013) 0.79
Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development. Mol Cell Biol (2014) 0.79
Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesis. Front Immunol (2014) 0.79
Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma. Am J Pathol (2000) 0.78
RNA Exosome Regulates AID DNA Mutator Activity in the B Cell Genome. Adv Immunol (2015) 0.78
Human memory B cells. Leukemia (2016) 0.77
Nbs1 ChIP-Seq Identifies Off-Target DNA Double-Strand Breaks Induced by AID in Activated Splenic B Cells. PLoS Genet (2015) 0.77
Comparison of identical and functional Igh alleles reveals a nonessential role for Eμ in somatic hypermutation and class-switch recombination. J Immunol (2010) 0.77
Integrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphoma. Sci Rep (2017) 0.76
Lysine residue at position 22 of the AID protein regulates its class switch activity. PLoS One (2012) 0.76
The pattern of somatic hypermutation of Ig genes is altered when p53 is inactivated. Mol Immunol (2010) 0.76
B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes. J Virol (2012) 0.76
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization. Am J Pathol (2002) 0.75
The rate of mutation of a single gene. Nucleic Acids Res (2009) 0.75
YY1 Regulates the Germinal Center Reaction by Inhibiting Apoptosis. J Immunol (2016) 0.75
AID to overcome the limitations of genomic information by introducing somatic DNA alterations. Proc Jpn Acad Ser B Phys Biol Sci (2006) 0.75
Point mutation of 5' noncoding region of BCL-6 gene in primary gastric lymphomas. World J Gastroenterol (2005) 0.75
The role of aberrant proteolysis in lymphomagenesis. Curr Opin Hematol (2015) 0.75
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutation analysis pipeline. BMC Bioinformatics (2013) 0.75
The reverse transcriptase model of somatic hypermutation. Philos Trans R Soc Lond B Biol Sci (2001) 0.75
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer? Cold Spring Harb Mol Case Stud (2017) 0.75
Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma. For Immunopathol Dis Therap (2015) 0.75
Clonal selection and learning in the antibody system. Nature (1996) 9.58
Intraclonal generation of antibody mutants in germinal centres. Nature (1991) 7.39
Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science (1997) 6.58
Maturation of the immune response in germinal centers. Cell (1991) 5.68
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science (1993) 3.89
Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J (1993) 3.85
Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim Biophys Acta (1992) 3.75
Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity (1996) 3.39
Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science (1998) 3.22
BCL-6 protein is expressed in germinal-center B cells. Blood (1995) 3.18
BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci U S A (1996) 3.10
Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell (1994) 3.06
Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene. J Exp Med (1990) 2.98
LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet (1993) 2.49
The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today (1994) 2.44
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Patterns of somatic mutations in immunoglobulin variable genes. Genetics (1987) 2.24
Somatic hypermutation in normal and transformed human B cells. Immunol Rev (1998) 2.22
Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17
Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A (1998) 2.16
Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A (1995) 2.13
Transcriptional repression by the proto-oncogene BCL-6. Oncogene (1996) 1.94
Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol (1993) 1.85
Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol (1997) 1.80
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80
BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood (1995) 1.79
The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ (1995) 1.68
Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol Rev (1998) 1.51
Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol (1993) 1.38
Locus-specific somatic hypermutation in germinal centre T cells. Nature (1994) 1.28
Somatic hypermutation of the T cell receptor V beta gene in microdissected splenic white pulps from HIV-1-positive patients. Eur J Immunol (1998) 1.11
Magnetofluorescent liposomes for increased sensitivity of immunofluorescence. Immunotechnology (1995) 1.03
Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood (1997) 0.99
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
Inducible gene targeting in mice. Science (1995) 21.22
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science (1994) 13.47
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell (1993) 11.76
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1982) 11.15
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region. Cell (1981) 9.54
Generation and analysis of interleukin-4 deficient mice. Science (1991) 8.80
Intraclonal generation of antibody mutants in germinal centres. Nature (1991) 7.39
In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell (1997) 7.18
Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature (1982) 6.78
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature (2001) 6.70
A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc Natl Acad Sci U S A (1974) 6.51
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med (2001) 5.66
The requirement of more than one antigenic determinant for immunogenicity. J Exp Med (1969) 5.61
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A (1997) 5.43
B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res (1997) 5.43
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06
Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature (1996) 4.95
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia (2009) 4.91
Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol (1975) 4.79
Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A (1982) 4.70
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59
A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet (1999) 4.14
Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (1995) 4.10
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
Direct activation of TERT transcription by c-MYC. Nat Genet (1999) 3.98
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science (1993) 3.89
Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J (1993) 3.85
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell (1991) 3.84
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84
Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science (1983) 3.82
Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature (1992) 3.82
Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell (1999) 3.76
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1991) 3.69
Ku80 is required for immunoglobulin isotype switching. EMBO J (1998) 3.67
NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell (2000) 3.60
Most peripheral B cells in mice are ligand selected. J Exp Med (1991) 3.50
Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response. Eur J Immunol (1978) 3.48
Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Nature (1978) 3.45
Contribution of receptor editing to the antibody repertoire. Science (2001) 3.45
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 3.43
Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med (1998) 3.37
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37
Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron (2001) 3.37
Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene (2001) 3.32
BCL-6 protein is expressed in germinal-center B cells. Blood (1995) 3.18
MHC class I expression in mice lacking the proteasome subunit LMP-7. Science (1994) 3.17
Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature (1990) 3.14
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood (2000) 3.13
Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature (1996) 3.11
BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci U S A (1996) 3.10
A critical role of lambda 5 protein in B cell development. Cell (1992) 3.09
Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product. Proc Natl Acad Sci U S A (1983) 3.03
Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci U S A (1982) 3.02
Aberrant B cell development and immune response in mice with a compromised BCR complex. Science (1996) 3.01
Shutdown of class switch recombination by deletion of a switch region control element. Science (1993) 2.99
Cellular origin of human B-cell lymphomas. N Engl J Med (1999) 2.91
Memory B-cell persistence is independent of persisting immunizing antigen. Nature (2000) 2.90
Analysis of the repertoire of anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in C 57 BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies. Eur J Immunol (1979) 2.87
A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science (1995) 2.84
In situ localization of human fibronectin (FN) genes to chromosome regions 2p14----p16, 2q34----q36, and 11q12.1----q13.5 in germ line cells, but to chromosome 2 sites only in somatic cells. Cytogenet Cell Genet (1986) 2.83
Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J (1988) 2.81
Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature (1995) 2.78
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med (1996) 2.75
The half-lives of serum immunoglobulins in adult mice. Eur J Immunol (1988) 2.73
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
Quantitative noise analysis for gene expression microarray experiments. Proc Natl Acad Sci U S A (2002) 2.66
Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood (1997) 2.64
EFA6, a sec7 domain-containing exchange factor for ARF6, coordinates membrane recycling and actin cytoskeleton organization. EMBO J (1999) 2.63
Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 2.60
BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol (2000) 2.58
Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med (2001) 2.57
Antigen receptors of T helper cells. Contemp Top Immunobiol (1977) 2.54
PCR-based cDNA library construction: general cDNA libraries at the level of a few cells. Nucleic Acids Res (1989) 2.48
Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses. Cell (1987) 2.47
Recognition of idiotypes in lymphocyte interactions. II. Antigen-independent cooperation between T and B lymphocytes that possess similar and complementary idiotypes. Eur J Immunol (1978) 2.47